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Abstract
BACKGROUND AND PURPOSE—High resolution, vascular magnetic resonance imaging of the
spine region in small animals poses several challenges. The small anatomical features, extravascular
diffusion, and the low signal-to-noise ratio limit the use of conventional contrast agents. We
hypothesize that a long circulating, intravascular liposomal-encapsulated MR contrast agent
(liposomal-Gd) would facilitate visualization of small anatomical features of the perispinal
vasculature not visible with conventional contrast agent (Gd-DTPA).
METHODS—In this study, high-resolution magnetic resonance angiography (MRA) of the spine
region was performed in a rat model using a liposomal-Gd, which is known to remain within the
bloodpool for an extended period. The imaging characteristics of this agent were compared to a
conventional, Gd-DTPA.
RESULTS—The liposomal-Gd enabled acquisition of high quality angiograms with high signal-
to-noise ratio. Several important vascular features such as radicular arteries, posterior spinal vein
and epidural venous plexus were visualized in the angiograms obtained with the liposomal agent.
The MR angiograms obtained with conventional Gd-DTPA did not demonstrate these vessels clearly
due to marked extravascular soft-tissue enhancement that obscured the vasculature.
CONCLUSIONS—This study demonstrates the potential benefit of long circulating liposomal-Gd
as a MR contrast agent for high-resolution vascular imaging applications.
Introduction
Compromised vasculature is implicated in a number of spine pathologies (1,2). Moreover,
demonstration of perispinal vasculature is important for presurgical planning (3). Imaging of
mid and large vascular structures is aided by the use of exogenous contrast agents that are
typically imaged on first-pass through the arterial circuit using a fast acquisition, which is
referred to as Contrast Enhanced Magnetic Resonance Angiography or CE-MRA (4,5,6).
Unfortunately, the role of CE-MRA has been limited in the evaluation of smaller vessels, due
to the long scan times required and the resulting venous contamination.
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Rodent models are commonly used to study spinal cord pathologies, particularly spinal cord
injury (SCI) (7,8,9,10,11,12). Magnetic resonance angiography of the spine in rodents
however, presents unique challenges because of the small size of the blood vessels
(approximately 100–300 μm). Visualization of these vessels with high signal-to-noise ratio
(SNR) requires significant signal averaging and involves relatively long acquisition times.
In the present work, we report the use of gadolinium-encapsulated long circulating liposomes
(liposomal-Gd) for high resolution MR imaging of the rat spinal vasculature. Although there
is some variability in the literature, we define high resolution MRA as imaging at spatial
resolution of approximately 100 μm, and use it as such in the present context. Long circulating
liposomes are nanoparticles (~ 100 nm) bearing hydrophilic polyethylene glycol (PEG) chains
on their external surface. The PEG coating prevents opsonization, and prolongs circulation
half-life to around 18 hours (13). The long intra-vascular half-life of this agent results in stable
levels of contrast agent within the blood pool for many hours, thus enabling a longer image-
acquisition time window. Beyond this, there is relative lack of enhancement of the adjacent
extravascular tissue that results in a high contrast-to-noise ratio. We therefore hypothesize that
a long circulating, intravascular liposomal-encapsulated MR contrast agent (liposomal-Gd)
would facilitate visualization of small anatomical features of the perispinal vasculature in a rat
model not visible with conventional contrast agent (Gd-DTPA).
Methods
Liposomal-Gd Preparation
Liposomal-Gd was prepared by modification of methods described previously (14,15). Briefly,
a lipid mixture consisting of 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)
(Genzyme, MA), Cholesterol (Sigma, St Louis, MO) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(poly(ethylene glycol))-2000] (mPEG2000-DSPE)
(Genzyme, MA) in the ratio 55:40:5 was dissolved in ethanol at 60°C. The ethanol solution
was then hydrated with 0.5 M gadodiamide (Omniscan® - Gd-DTPA BMA) solution and stirred
for 1 hr at 60°C. The resulting liposomal solution was sequentially extruded at 60°C on Lipex
Thermoline extruder (Northern Lipids, Vancouver, Canada) with three passes through 0.4 μm
Nuclepore membrane (Waterman, Newton, MA), five passes through 0.2 μm Nuclepore
membrane and eight passes through 0.1 μm Nuclepore membrane. The external phase was then
cleaned and the liposomes simultaneously concentrated by diafiltration using MicroKros
modules (Spectrum Laboratories, CA) of 50 nm cutoff. The size of the resultant liposomal
formulations obtained was determined by dynamic light scattering (DLS) using a Brookhaven
Instruments BI-9000AT Digital Autocorrelator, a BI-200SM goniometer (JDS Uniphase; San
Jose, CA) and a Hamamatsu photomultiplier (supplied by Brookhaven, Long Island, NY). The
resultant size of liposomes in the formulation as determined using DLS was 105 nm with a
polydispersity index of 0.107.
The concentration of gadolinium in the liposomal-Gd formulation was determined by
inductively coupled plasma atomic emission spectroscopy (ICP-AES). The average
concentration of Gd in the formulation was found to be 90 mM. To determine the in-vitro molar
T1 relaxivity of the liposomal-Gd formulation, samples with Gd concentrations ranging
between 0.5 mM – 2 mM (4 samples) were prepared by diluting the original liposomal
formulation with phosphate buffered saline. The T1 relaxation times of the samples were then
determined on a 7 Tesla Bruker scanner using a multi-spin multi-echo (MSME) sequence with
the following parameters: TE = 9 ms, TR was varied from 40 – 16000 ms. A plot of the T1
relaxation rates versus Gd concentrations yielded a straight line with the slope as the in-vitro
T1 relaxivity of the formulation, which was found to be 0.8 (mM.s)−1.
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All animal studies were performed under a protocol approved by the Animal Welfare
Committee of the University of Texas – Houston Health Science Center. Five Sprague–Dawley
rats weighing between 350–390 g were used in this study. After spontaneous inhalation of 4%
isoflurane, the animal was intubated and maintained under anesthesia by ventilating a mixture
of 2% isoflurane, 30% oxygen and air with a vaporizer (Isotec3, Ohmeda, UK) and
administered through a Harvard rodent ventilator (South Natick, MA). The left jugular vein
was cannulated for intravenous delivery of the contrast agent, as described previously (16). A
rectangular coil (11 × 35 mm) was implanted in the back of the animal and centered at the T7
level and inductively coupled to an external surface coil (30 × 40 mm) for improved image
quality (17). The animal was placed in the supine position over the external coil on a custom-
built Plexiglas sled and the entire assembly was inserted into the bore of the magnet. The body
temperature was maintained at 37°C by circulating warm water through the animal bed
throughout the MRI scan.
MRI Protocol
All MR studies were performed on a 7 Tesla Bruker scanner, 70/30 URS (Bruker Biospec,
Karlsruhe, Germany) using a 116-mm shielded gradient insert that is capable of producing a
maximum gradient amplitude of 400 mT/m with 80-μs rise time. Following the acquisition of
orthogonal scout image for animal positioning, anatomical images were obtained using T1-
weighted spin echo sequence with TE/TR = 10.4/500 ms, 26 mm field of view, and 20
interleaved contiguous axial slices, each 1 mm thick. Preliminary scans were performed for
optimizing the scan parameters (echo time, repetition time and flip angle) for MRA, and the
same parameters were utilized for all the subsequent scans.
Standard Resolution Studies—Pre-contrast, post-liposomal-Gd and post-Gd-DTPA
images were acquired as described below. Separate animals were used to evaluate Gd-DTPA
and liposomal-Gd to avoid confounding issues that could result from interactions between the
two contrast agents. The images were acquired using a flow compensated fast 3D gradient-
echo (GE) sequence with the following parameters: TR/TE = 18.3/2.8 ms, flip angle = 30
degrees, image matrix = 128 × 128 × 64, FOV = 41 mm × 28 mm × 25 mm, and bandwidth =
200 KHz. The data was acquired with one signal average, thus resulting in a scan time of 2.5
minutes. Signal from the surrounding tissue was reduced by incorporating a 1 ms long
magnetization transfer pulse with a frequency offset of 1500 Hz. For the Gd-DTPA study, pre-
contrast images were acquired followed by administration of Gd-DTPA at a dose of 0.1 mmol/
kg. The data acquisition for post- Gd-DTPA images was started immediately and subsequent
images were acquired over the next 30 minutes. For the liposomal-Gd study, pre-contrast
images were acquired followed by administration of liposomal-Gd at a dose of 0.1 mmol/kg.
Post- liposomal-Gd images were acquired at 30 minutes post-liposomal administration. Images
for MRA were acquired without cardiac or respiratory gating. Maximum intensity projections
(MIP) (generated using Paravision 3.0.2 software or NIH Image J software) were used to
visualize the angiograms. Contrast-to-noise ratios (CNR) were calculated for regions of interest
(ROI) in the aorta, epidural venous plexus, intercostal arteries and hemi-azygous vein. The
contrast-to-noise ratio was calculated by subtracting the average signal intensity in the
surrounding tissues from the average signal intensity within the blood vessel and then dividing
this difference by the standard deviation of the signal intensity within the background (air).
High-Resolution Studies—A high spatial resolution acquisition was performed following
the injection of 0.1 mmol/kg of Gd in the form of liposomal-Gd through the jugular vein using
the previously implanted catheter. Imaging was performed using a flow compensated fast 3D
gradient-echo (GE) sequence with the following parameters: TR/TE = 18.3/2.8 ms, flip angle
= 30 degrees, image matrix = 256 × 256 × 256, FOV = 41 mm × 28 mm × 25 mm, and bandwidth
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= 200 KHz. A voxel size of 160 μm × 09 μm × 98 μm was achieved using the above parameters.
The number of signal averages was set to 3. The scan time for one signal average was 20
minutes. Signal from the surrounding tissue was reduced by incorporating a 1 ms long
magnetization transfer pulse with a frequency offset of 1500 Hz. Images for MRA were
acquired without cardiac or respiratory gating. Maximum intensity projections (MIP)
(generated using Paravision 3.0.2 software or NIH Image J software) were used to visualize
the angiograms. Using the method described above, contrast-to-noise ratios (CNR) were
calculated for regions of interest in the posterior spinal vein, epidural venous plexus, anterior
spinal artery and radicular artery (of Adamkiewicz).
Results
For the standard resolution study, maximum intensity projection (MIP) images of the thoracic
spinal region in the coronal plane were generated from acquisitions obtained prior to and
following the administration of liposomal-Gd and Gd-DTPA (Figure 1). The descending aorta
(Ao) and some of the intercostal arteries (IA) are visible on the pre-contrast image. The Gd-
DTPA post-contrast image shows relatively poor image-contrast between the vasculature and
the surrounding tissue, due to enhancement of the extravascular tissues, presumably due to
diffusion of the Gd-DTPA into the extracellular space. The scans acquired over the next 30
minutes did not show any improvement in image quality. Conversely, the post-liposomal-Gd
images showed clear vessel enhancement and negligible tissue enhancement. Given this good
target-to-background contrast, more perispinal vasculature is demonstrable on the post
liposomal-Gd images. In fact, the intravascular enhancement observed is greater for the post-
Gd-DTPA study, than for the post-liposomal-Gd study. However the contrast-to-noise ratios
for Gd-DTPA images were lower than liposomal-Gd images (Table 1). (Subtle differences in
image orientation in the post-contrast images in Figures 1 are of secondary importance
compared to slice-selection differences between the datasets which were acquired using two
different animals.)
For the high-resolution study, MIP images of the thoracic spinal region were generated in the
coronal plane before and after administration of liposomal-Gd (Figure 2). The post-contrast
images demonstrate several small blood vessels in the vicinity of the spinal cord, the epidural
venous plexus (VP), and the posterior spinal vein (PSV) along the dorsal surface of the spinal
cord. The contrast-to-noise ratios for liposomal-Gd images were higher than pre-contrast
images. (Table 2).
Axial images from the post-liposomal Gd volume acquisition of the mid thoracic spine were
also reviewed (Figure 3). The hemiazygous vein (HV) is clearly seen in this image. The
descending aorta and a section of the inferior vena cava are also visible. In addition, unnamed
perforating vessels are identified penetrating the ventral spinal cord (Figure 3b, 3d). Artifacts
due to the presence of the surgically-implanted radio-frequency coil within the soft tissues of
the back are also visible in all the images. The posterior spinal vein (PSV), anterior spinal artery
(ASA), and radicular arteries (including presumably the artery of Adamkiewicz (AA) with its
characteristic hairpin turn) are identified on the MIP images generated in the coronal plane
(Figure 4).
Discussion
Small animal vascular MR imaging of the spine poses several challenges. The majority of the
perispinal vessels are ≤ 300 μm in size (18), and the vessels within the spinal cord are ≤150
μm in size. Imaging these micro-vessels necessitates a large image acquisition matrix size
(small voxel size) to achieve the required high spatial resolution. Unfortunately, this results in
a concomitant reduction in the SNR. To overcome this penalty in SNR imposed by the
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acquisition matrix, data have to be acquired with several signal averages that, unfortunately
comes at the cost of longer acquisition times.
The majority of studies of rodent spinal vasculature done to date have therefore been based on
invasive imaging. Tveten et al. investigated the vasculature of the rat spinal region using
microangiographic and stereomicroscopic techniques (19,20). Koyangi et al. have analyzed
the rat spinal cord vasculature with scanning electron microscope examination of a vascular
corrosion cast (17). MRI techniques have not yet yielded sufficient information on the
vasculature. For instance, Bilgen et al. studied spinal MRA at 9.4 T without the use of any
exogenous contrast agent and in conjunction with the time-of-flight technique (21). Although
some of the intercostal arteries were visible, the lack of contrast agent within the vasculature
for a sustained interval prevented high-resolution studies, and also precluded visualization of
intra-cord vasculature. Yet, the promise of high resolution, non-invasive imaging is alluring
and motivates the current work.
An ideal contrast agent for this type of data acquisition (long-duration, large image matrix)
should have the following characteristics: (1) the contrast agent must remain confined to the
vasculature, and (2) maintain a relatively constant concentration (low elimination, dilution and
redistribution during the period of the data acquisition). If the contrast agent exits the
intravascular space during the acquisition period, the CE-MRA images are degraded for two
reasons. First, the relaxation time of blood is increased and the signal from blood is reduced
at short TR. Second, the contrast agent diffuses into the surrounding tissue and reduces the
relaxation time, resulting in increased signal from the surrounding tissue. As a result, the image-
contrast between blood vessels and the surrounding tissues (target-to-background) is reduced
and compromises the quality of MRA. Thus, as demonstrated in the current studies,
conventional low molecular-weight agents such as Gd-DTPA are not well suited for high
resolution MRA. Another important parameter that determines the quality of angiograms is
the blood elimination rate of contrast agent. The conventional contrast agents are eliminated
rapidly from blood circulation through renal clearance. Although they do not penetrate the
blood spinal cord barrier (BSCB), the rapid clearance of these contrast agents from blood
circulation limits their use in acquiring angiograms with long scan times.
Liposomal-Gd has several advantages over conventional low molecular-weight gadolinium
chelates. The long intravascular half-life of liposomal-Gd allows for stable opacification of the
blood vessels for the duration required for acquisition of high-resolution images. Furthermore,
the nano-size of these agents restricts their circulation to the vascular compartment, in regions
of low capillary leak, and limits diffusion away from the vasculature in regions of high vascular
permeability. The result of these two features is to limit the amount of enhancement of the
extravascular tissues. Although the vascular signal intensities in the post- Gd-DTPA images
were higher than in liposomal-Gd images, the contrast-to-noise ratios obtained with liposomal-
Gd were higher than Gd-DTPA (Table 1). Rapid diffusion of Gd-DTPA into the extravascular
compartment is likely responsible for the enhancement of the extravascular soft tissues that
results in poor contrast between the vessels and the surrounding tissues. Acquiring high-
resolution images with Gd-DTPA would therefore be expected to result in even more indistinct
angiograms due to: 1) significant extravascular diffusion during long scan times, and 2)
elimination from systemic circulation due to renal clearance.
The high-resolution angiograms obtained with liposomal-Gd demonstrated very good
microvessel conspicuity (Figure 2). The posterior spinal vein, anterior spinal artery and
radicular arteries were clearly demonstrated in the MIP images (Figure 4). The intravascular
nature of the liposomal-Gd agent also enabled visualization of the epidural venous plexus. The
epidural venous plexus, which consists of a lattice of fine venules, has an amorphous
appearance, rather than discrete because the diameters of these fine venules are much smaller
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than the voxel size of the image acquisition. The contrast-to-noise ratios in the post-liposomal-
Gd images were significantly higher than pre-contrast images (Table 2).
In addition to the liposomal-Gd agent, several other factors were critical in obtaining the high
quality angiograms. A radio-frequency coil was surgically implanted within the soft tissues of
the back of the animal and inductively coupled to an external surface coil. This enabled imaging
with high SNR which resulted in demonstration of several perispinal microvessels (Figure 4).
A short echo time was used in the gradient echo sequence to obtain a more heavily T1-weighted
image. The repetition time was maintained as short as possible to reduce the overall scan time
and thus allow for several signal averages.
While the current studies demonstrate extra-spinal cord vasculature with much detail, we have
not been able to visualize the vessels within the spinal cord because of the resolution limitations
and the low relaxivity of the liposomal-Gd agent. The ability to non-invasively visualize intra-
spinal cord vasculature would greatly help in defining the vascular lesions and microvascular
reorganization in spinal cord injury (22). It may also be possible to increase the image resolution
by increasing the image matrix with concomitant increase in the scan time. However, this
approach may be limited by morbidity and mortality associated with long anesthetic times.
With the development of parallel imaging technology this limitation could be overcome to a
great extent (23).
The encapsulation of Gd-DTPA within the core of the liposomes results in limited water
exchange across the lipid bilayer. The molar relaxivity of gadolinium encapsulated within
liposomes is far lower than that observed in unencapsulated (free) Gd-DTPA. The
encapsulation of Gd-DTPA inside these liposomes also alters the pharmacokinetics of Gd-
DTPA. The clearance of liposomal-Gd occurs through the organs of reticulo-endothelial
system (RES), namely liver and spleen, rather than the kidneys. Further in vivo studies should
be done to investigate the possible concerns associated with the altered pharmacokinetics of
the agent.
A unique characteristic of long circulating liposomes is the ability to extravasate only from
abnormal, leaky vessels. This property has been extensively exploited to deliver
chemotherapeutic agents to solid tumors (24). For grading and imaging solid tumors, the same
characteristic of liposomal particles could therefore be utilized to overcome the confounding
issues with conventional Gd-DTPA agent, which also leaks in normal micro-vasculature
(25). The encapsulation of gadolinium chelates within the liposomal interior also enables easy
modification of the outer surface of the liposomes for actively targeting the contrast agents to
specific sites (such as tumors, inflammation, injury etc).
Conclusions
The liposomal-Gd enabled acquisition of angiograms with higher microvessel conspicuity than
conventional Gd-DTPA. This was due to the relative lack of extravascular enhancement that
resulted in improved target-to-background contrast. In addition, the prolonged intravascular
residence time of liposomal-Gd allowed for longer scans, thus facilitating high-resolution
angiograms.
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Coronal MIP images of the thoraco-lumbar spine region acquired (a) pre-contrast, (b) post-
liposomal-Gd and (c) post- Gd-DTPA. The images were acquired using the following
parameters: TR/TE = 18.3/2.8 ms, flip angle = 30 degrees, image matrix = 128 × 128 × 64,
FOV = 41 mm × 28 mm × 25 mm, No. of signal average = 1. The total scan time was 2.5
minutes. The descending aorta (Ao), and intercostal arteries (IA) are demonstrated in the pre-
contrast image (a). The epidural venous plexus (VP), and more details about the intercostal
arteries are demonstrated in post- liposomal-Gd image (b). The tissue enhancement due to
diffusion of Gd-DTPA into the extravasacular space is shown in post- Gd-DTPA image (c).
Post- liposomal-Gd and post- Gd-DTPA images were acquired in different animals.
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Coronal MIP images of the thoraco-lumbar spine region acquired before (left) and after (right)
administration of liposomal-Gd. The images were acquired using the following parameters:
TR/TE = 18.3/2.8 ms, flip angle = 30 degrees, image matrix = 256 × 256 × 256, FOV = 41 mm
× 28 mm × 25 mm, No. of signal average = 3. The epidural venous plexus (1) and the posterior
spinal vein (2) are clearly visible in the post- liposomal-Gd image.
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Pre-contrast (top row) and post-contrast (bottom row) axial slices at different locations through
the thoraco-lumbar spine region showing several important vascular features (aorta- Ao;
inferior vena cava– IVC; hemi-azygous vein – HV). Blood vessels penetrating the spinal cord
can be visualized in figure 3(d) and (e) (arrow). The epidural venous plexus is demonstrated
in figure 3(f). The artifacts due to the implantation of radio-frequency coil on the dorsal side
are also visible. These images are acquired after administration of liposomal-Gd.
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Coronal MIP images of the thoraco-lumbar spine region obtained with liposomal-Gd. The
posterior spinal vein (PSV) is clearly seen in figure 4a (arrows). The anterior spinal artery
(arrowheads), the artery of Adamkiewicz (AA) and an accessory anterior radicular artery
(ARA) can be clearly seen in figure 4b.
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Table 1
Contrast-to-noise ratio (CNR) for anatomical features in standard-resolution images obtained with Gd-DTPA to
images obtained with liposomal-Gd.
Anatomical Feature Gd-DTPA Liposomal-Gd
Epidural venous plexus 8.2 21.0
Intercostal arteries 13.2 22.0
Hemi-azygous vein 19.8 36.4
Aorta 8.3 18.2
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Table 2
Contrast-to-noise ratio (CNR) for anatomical features in high-resolution images obtained pre-contrast and after
administration of liposomal-Gd.
Anatomical Feature Pre-contrast Liposomal-Gd
Epidural venous plexus −0.1 6.5
Posterior spinal vein −0.5 2.3
Anterior spinal artery 1.4 4.1
Radicular artery (of Adamkiewicz) 3.2 6.8
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